News for 'SARS'

Vaccines will work against new COVID-19 variant: Govt

Vaccines will work against new COVID-19 variant: Govt

Rediff.com29 Dec 2020

'Most vaccines do target the Spike protein, in which there are changes in the variants but vaccines stimulate our immune system to produce a wide range of protective antibodies'

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

Hema Malini's Stunning Dance Performance

Hema Malini's Stunning Dance Performance

Rediff.com5 Jan 2022

The Top Videos of the Week!

'Delta plus' variant may trigger 3rd wave in Maha: State health dept

'Delta plus' variant may trigger 3rd wave in Maha: State health dept

Rediff.com17 Jun 2021

The highly virulent 'Delta plus' variant of the novel coronavirus could stoke a third wave in Maharashtra, according to a presentation made at a meeting attended by Chief Minister Uddhav Thackeray.

'Vaccine Must Go To Older People First'

'Vaccine Must Go To Older People First'

Rediff.com9 Nov 2021

'At the current time, we should be vaccinating all those who are potentially going to get more severe illness, before we start vaccinating very young individuals.'

Delta variant 8 times less sensitive to vaccines: Study

Delta variant 8 times less sensitive to vaccines: Study

Rediff.com5 Jul 2021

The study, which was conducted on more than 100 healthcare workers at three centres in India including Sir Ganga Ram Hospital, found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections (Ct value of 16.5 versus 19) but also generates greater transmission among the fully vaccinated HCWs.

WHO questions fall in SARS cases in China

WHO questions fall in SARS cases in China

Rediff.com3 Jun 2003

The United Nations health agency said it was 'concerned' at how the counting was being done.

Blanket bans can be counterproductive: WHO India head

Blanket bans can be counterproductive: WHO India head

Rediff.com18 Jan 2022

Stressing on the need to protect both lives and livelihoods, he said public health action in India and across the world must be continually guided by evidence from four key questions -- how transmissible is the variant, severity of the disease it causes, how well vaccines and prior SARS-CoV-2 infection protect and how common people perceive risk and follow control measures.

Good news! Fall in new Covid cases in Kerala, Maharashtra

Good news! Fall in new Covid cases in Kerala, Maharashtra

Rediff.com18 Aug 2021

After breaching the value of 1 in the first week of August, the R number, which reflects how rapidly the coronavirus pandemic is spreading, has been steadily ebbing, according to researchers at the Institute of Mathematical Sciences, Chennai.

Maha, Kerala, K'taka log more Omicron cases; India's tally rises to 126

Maha, Kerala, K'taka log more Omicron cases; India's tally rises to 126

Rediff.com18 Dec 2021

The Centre has warned it is likely that the spread of the new variant will outpace the Delta variant where there is community transmission.

India reports 6 cases of UK coronavirus strain

India reports 6 cases of UK coronavirus strain

Rediff.com29 Dec 2020

All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.

Oxford launches COVID-19 vaccine study on children

Oxford launches COVID-19 vaccine study on children

Rediff.com13 Feb 2021

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

Omicron's mildness a 'mistake', Covid not getting milder: UK expert

Omicron's mildness a 'mistake', Covid not getting milder: UK expert

Rediff.com6 Jan 2022

The reduced severity of the Omicron variant is good news for now, but it is the result of an 'evolutionary mistake' and does not indicate that the virus which causes COVID-19 is becoming less virulent, a leading Indian-origin scientist from the University of Cambridge warned on Thursday.

Does India need booster shots to fight Omicron?

Does India need booster shots to fight Omicron?

Rediff.com12 Dec 2021

'Better to prevent than to wait for evidence. Protection delayed can also mean protection denied'

Equities outperform bonds in the ultra-long run, says study

Equities outperform bonds in the ultra-long run, says study

Rediff.com16 Mar 2021

Ultra-long term equity investments have been a lot more rewarding than debt, a study published by Credit Suisse Research Institute in collaboration with London Business School shows. "Over the last 121 years, global equities have provided an annualised real return (in dollar terms) of 5.3 per cent versus 2.1 per cent for bonds," shows the study, which has looked at returns for 23 countries since 1900. In the Indian context, equity returns are even more favourable. Since 1953, equities have generated annualised returns of 6.5 per cent and government bonds only 0.4 per cent.

Health secy reviews status of passengers from UK

Health secy reviews status of passengers from UK

Rediff.com23 Dec 2020

Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.

Delta variant may spread as easily as chickenpox: Reports

Delta variant may spread as easily as chickenpox: Reports

Rediff.com30 Jul 2021

The Delta variant is more transmissible than the viruses that cause MERS, SARS, Ebola, the common cold, the seasonal flu and smallpox, and it is as contagious as chickenpox, according to the document, a copy of which was also obtained by The New York Times.

Saudi Arabia suspends international travel over new Covid strain

Saudi Arabia suspends international travel over new Covid strain

Rediff.com21 Dec 2020

All people who have arrived in Saudi Arabia from European countries, as well as other states where the new coronavirus strain has emerged, will have to self-isolate at home for two weeks. Those who have visited these countries in the past three months will need to get tested for Covid-19, according to SPA.

How Gulzar created Chhaiyyan Chhaiyyan

How Gulzar created Chhaiyyan Chhaiyyan

Rediff.com31 Jan 2019

'I believe after Shailendra's Mera Joota Hai Japaani in Raj Kapoor's Shree 420, Chhaiyyan Chhaiyyan is now the Indian film song that is recognised the world over -- millions know it as 'the train song'.'

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Rediff.com27 Jul 2021

An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covid vaccine Covovax on children aged 2 to 17 years with certain conditions, official sources said.

After slowing down in early August, Covid spread rises sharply

After slowing down in early August, Covid spread rises sharply

Rediff.com3 Sep 2021

The R-value, which reflects how rapidly coronavirus pandemic is spreading, has sharply risen close to 1.2 over the last fortnight, mainly driven by cases in states like Kerala and Maharashtra, say researchers.

Pfizer jab produces less antibodies against Delta variant: Study

Pfizer jab produces less antibodies against Delta variant: Study

Rediff.com4 Jun 2021

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

Don't wait for economy to recover. Invest NOW!

Don't wait for economy to recover. Invest NOW!

Rediff.com10 Jul 2020

'If we wait to invest only after the economy recovers fully, it might be too late,' advises Vivek Jain, business unit head-investments, Policybazaar.com.

New smartphone-based COVID test gives results in less than 30 minutes

New smartphone-based COVID test gives results in less than 30 minutes

Rediff.com7 Dec 2020

The research found that the device accurately detected a set of positive samples in under 5 minutes.

Omicron: PM asks officials to review easing international travel curbs

Omicron: PM asks officials to review easing international travel curbs

Rediff.com27 Nov 2021

Prime Minister Narendra Modi was on Saturday briefed about the new 'Omicron' variant of the coronavirus, and he asked officials to review the plans to ease international travel restrictions in light of the 'emerging new evidence.'

Wastewater containing coronavirus may be potential threat

Wastewater containing coronavirus may be potential threat

Rediff.com25 Aug 2020

According to the scientists, sewage leaking into natural watercourses might lead to infection with the novel coronavirus SARS-CoV-2 via airborne spray.

Long Covid has more than 200 symptoms: Study

Long Covid has more than 200 symptoms: Study

Rediff.com15 Jul 2021

The most common symptoms were fatigue, post-exertional malaise -- worsening of symptoms after physical or mental exertion -- and cognitive dysfunction, often called brain fog.

Covid like a Test match, not ODI: AIIMS taskforce chief

Covid like a Test match, not ODI: AIIMS taskforce chief

Rediff.com20 May 2021

Chairperson of the COVID Task Force for All India Institute of Medical Sciences, Dr Naveet Wig on Thursday said that the COVID-19 crisis is 'a dynamic situation' and to prevent a third wave of the pandemic, there is a need to keep changing strategies.

Second round of sero survey begins in Mumbai

Second round of sero survey begins in Mumbai

Rediff.com10 Aug 2020

The study will provide information about the spread of the infection and also throw light on herd immunity.

ICMR plans to scale-up testing capacity to 1 lakh/day

ICMR plans to scale-up testing capacity to 1 lakh/day

Rediff.com6 Apr 2020

The ICMR has approved over 200 labs (both public and private) for COVID-19 testing through-PCR machines.

Coronavirus can last on face masks for a week: Study

Coronavirus can last on face masks for a week: Study

Rediff.com6 Apr 2020

'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

Rediff.com17 Aug 2020

Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.

COVID-19 vaccine unlikely before Fall of 2021: Experts

COVID-19 vaccine unlikely before Fall of 2021: Experts

Rediff.com2 Oct 2020

Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020. The majority of those surveyed were mostly Canadian or American academics with an average of 25 years of experience working in the field.

'The faster one vaccinates, the lower the infections'

'The faster one vaccinates, the lower the infections'

Rediff.com1 Mar 2021

'We are not yet out of the woods.' 'If India sees the South African or Brazilian type of mutations, our numbers will rapidly rise.'

India-UK flights to remain suspended till Jan 7: Puri

India-UK flights to remain suspended till Jan 7: Puri

Rediff.com30 Dec 2020

The civil aviation ministry had last week suspended all flights between the European country and India from December 23 to December 31 as a mutated variant of the coronavirus was detected there.

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Rediff.com8 Aug 2021

The study titled 'Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime' has been uploaded on medRxiv, a preprint server and is yet to be peer reviewed.

2 cases of Omicron found in Karnataka, says govt

2 cases of Omicron found in Karnataka, says govt

Rediff.com2 Dec 2021

Two cases of the new Omicron variant of coronavirus have been detected in Karnataka, the Union government said on Thursday while asking people not to panic but follow Covid-appropriate behaviour and get vaccinated without delay.

Pfizer withheld Covid vaccine news before elections: Trump

Pfizer withheld Covid vaccine news before elections: Trump

Rediff.com10 Nov 2020

Trump had said that he worked on removing a large number of bureaucratic obstacles to fast-track development and approval of a vaccine.